在患有充血性心力衰竭的患者中,内源性ouabain度升高
S S Gottlieb1, A C Rogowski, M Weinberg
1Department of Medicine, University of Maryland School of Medicine, Baltimore 21201.
Circulation
|August 1, 1992
概括
内源性ouabain水平在心力衰竭患者中升高,与心脏功能降低相关. 这表明内源性乌阿巴因在人体平衡中发挥了作用,独立于液体体积.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 生理学 生理学 生理学
背景情况:
- 一种类似哺乳动物数字的化合物已经被理论化,最近在人体血中发现了ouabain.
- 充血性心力衰竭 (CHF) 患者可能存在内源性氨酸水平的变化.
- 由于其潜在的临床意义,研究内源性Ouabain在CHF中的病理生理学至关重要.
研究的目的:
- 在患有充血性心力衰竭的患者中评估内源性ouabain的病理生理学.
- 在CHF患者和对照人群中确定血ouabain度.
- 评估ouabain水平和CHF中的血液动力学参数之间的关系.
主要方法:
- 血ouabain度使用免疫试验进行测量.
- 包括51名心力衰竭患者和19名对照患者.
- 分析了ouabain水平与心脏指数,平均动脉压和填充压力之间的相关性.
主要成果:
- 与对照组相比,心力衰竭患者的血ouabain度显著增加.
- 奥阿巴因水平与心脏指数和平均动脉压相反相关.
- 在ouabain和左心室填充或右心房压力之间没有发现相关性,也没有与功能.
结论:
- 体积状态不是CHF中ouabain度的主要决定因素.
- 在CHF患者中内源性ouabain的升高表明它可能是显著的恒温因子.
- 这些发现暗示了内源性乌阿巴因在调节人类心血管功能的作用.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...


